Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

Radiological Investigation II: MRI and Ventilation Perfusion Scan

Radiological Investigation II: MRI and Ventilation Perfusion Scan

Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

WHO 2022 Renal Cell Tumor Classification: Imaging Features and Clinical Implications.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026

Same author

PRECISE Version 2: Essential Tips for Prostate Cancer Monitoring Using MRI.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026

Same author

European Society of Urogenital Radiology (ESUR) perspectives on the role of prostate MRI in active surveillance.

Insights into imaging·2026

Same author

ACR Appropriateness Criteria® Staging and Follow-Up of Adrenal Cancer.

Journal of the American College of Radiology : JACR·2026

Same author

ACR Appropriateness Criteria® Autosomal Dominant Polycystic Kidney Disease.

Journal of the American College of Radiology : JACR·2026

Same author

ACR Appropriateness Criteria® Renovascular Hypertension: Update 2026.

Journal of the American College of Radiology : JACR·2026

Search research articles

Related Experiment Video

Updated: Jun 16, 2025

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

PSMA-RADS 2.0: a revised framework for PSMA-targeted imaging interpretation and clinical decision-making.

Arwa Elsamny¹, Amr Wardeh², Alexandra Panyukova²

¹SUNY Upstate Medical University, Syracuse, USA. elsamnya@upstate.edu.

Abdominal Radiology (New York)

|June 13, 2025

Summary

This summary is machine-generated.

The updated Prostate-Specific Membrane Antigen - Radiotracer Imaging Reporting and Data System (PSMA-RADS) version enhances prostate cancer detection and clinical decision-making. This revised framework refines classifications for PSMA-targeted PET scans, improving accuracy in identifying cancer findings.

Keywords:

PSMA RADS PSMA PET/CT SUV threshold biochemical recurrence miPSMA score treatment response evaluation

More Related Videos

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Related Experiment Videos

Last Updated: Jun 16, 2025

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Area of Science:

Nuclear Medicine
Radiology
Oncology

Background:

Prostate-Specific Membrane Antigen - Radiotracer Imaging Reporting and Data System (PSMA-RADS) version 1 (2017) established a framework for classifying PSMA-targeted PET scans.
The initial version focused on findings outside the prostate using a five-point scale.
Limitations in the original PSMA-RADS necessitated an update to improve its clinical utility.

Purpose of the Study:

To explore the modifications introduced in the updated PSMA-RADS version.
To evaluate the impact of the revised PSMA-RADS on clinical management of prostate cancer.
To inform radiologists about advancements in PSMA-targeted imaging for better patient care.

Main Methods:

Review and analysis of the updated PSMA-RADS version (2022).
Comparison of the updated framework with the initial PSMA-RADS version (2017).
Exploration of lesion-level and patient-level classifications, including confidence and probability scores.

Main Results:

The updated PSMA-RADS version refines category definitions and addresses limitations of the initial scale.
The revised framework incorporates both lesion-level and patient-level classifications.
Enhanced confidence and probability scores are provided to support clinical decision-making.

Conclusions:

The updated PSMA-RADS version offers improved classification for PSMA-targeted PET scans.
The revised scale is expected to enhance the guidance of clinical decisions in prostate cancer management.
This advancement supports multidisciplinary collaboration and optimizes patient care through more accurate imaging interpretation.